{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:28:54Z","timestamp":1770823734257,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1245\/s10434-011-1593-7","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T15:38:38Z","timestamp":1297697918000},"page":"2407-2412","source":"Crossref","is-referenced-by-count":101,"title":["Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing Trial"],"prefix":"10.1245","volume":"18","author":[{"given":"Abigail S.","family":"Caudle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry M.","family":"Kuerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Meric-Bernstam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Bedrosian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gildy V.","family":"Babiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa F.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merrick I.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry W.","family":"Feig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K.","family":"Litton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul A.","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Mittendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"key":"1593_CR1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"A Giuliano","year":"1994","unstructured":"Giuliano A, Kirgan D, Guenther J, Morton D. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391\u20139.","journal-title":"Ann Surg."},{"key":"1593_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","volume":"222","author":"A Giuliano","year":"1995","unstructured":"Giuliano A, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394\u20139.","journal-title":"Ann Surg."},{"key":"1593_CR3","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology: breast, version 2.2008 (2008)."},{"key":"1593_CR4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.2005.04.5658","volume":"24","author":"G Lyman","year":"2006","unstructured":"Lyman G, et al. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2006;24:210\u20131.","journal-title":"J Clin Oncol."},{"key":"1593_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.21568","volume":"106","author":"T Kim","year":"2006","unstructured":"Kim T, Guiuliano A, Lyman G. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta-analysis. Cancer. 2006;106:4\u201316.","journal-title":"Cancer."},{"key":"1593_CR6","unstructured":"AJCC cancer staging manual. New York: Springer; 2009."},{"key":"1593_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02303847","volume":"5","author":"J Sosa","year":"1998","unstructured":"Sosa J, et al. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol. 1998;5:140\u20139.","journal-title":"Ann Surg Oncol."},{"key":"1593_CR8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0140-6736(92)91591-U","volume":"339","author":"P Cabanes","year":"1992","unstructured":"Cabanes P, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The breast carcinoma collaborative group of the Institut Curie. Lancet. 1992;339:1245\u20138.","journal-title":"Lancet."},{"key":"1593_CR9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bjs.4725","volume":"91","author":"G Cserni","year":"2004","unstructured":"Cserni G, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg. 2004;91:1245\u201352.","journal-title":"Br J Surg."},{"key":"1593_CR10","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/jnci\/djn343","volume":"100","author":"C Deurzen van","year":"2008","unstructured":"van Deurzen C, et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst. 2008; 100:1574\u201380.","journal-title":"J Natl Cancer Inst."},{"key":"1593_CR11","doi-asserted-by":"crossref","unstructured":"Yi M, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. 2010;17.","DOI":"10.1245\/s10434-010-1253-3"},{"key":"1593_CR12","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","volume":"27","author":"K Bilimoria","year":"2009","unstructured":"Bilimoria K, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009;27:2946\u201353.","journal-title":"J Clin Oncol."},{"key":"1593_CR13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"A Giuliano","year":"2010","unstructured":"Giuliano A, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American college of surgeons oncology group Z0011 randomized trial. Ann Surg. 2010; 252:426\u201332.","journal-title":"Ann Surg."},{"issue":"6","key":"1593_CR14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"A Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569-75.","journal-title":"JAMA."},{"key":"1593_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2004.04.065","volume":"61","author":"J Reznik","year":"2005","unstructured":"Reznik J, Cicchetti M, Degaspe B, Fitzgerald T. Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys. 2005;61:163\u20138.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"1593_CR16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0360-3016(01)01684-4","volume":"51","author":"P Schlembach","year":"2001","unstructured":"Schlembach, P, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001;51:671\u20138.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"1593_CR17","doi-asserted-by":"crossref","unstructured":"Leitch A, et al. Factors influencing accrual to ACOSOG Z011, a randomized phase III trial of axillary dissection vs. observation for sentinel node positive breast cancer. J Clin Oncol. 2006; 25:601.","DOI":"10.1200\/jco.2006.24.18_suppl.601"},{"key":"1593_CR18","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1245\/s10434-008-0153-2","volume":"15","author":"E Mittendorf","year":"2008","unstructured":"Mittendorf E, et al. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol. 2008;15:3369\u201377.","journal-title":"Ann Surg Oncol."},{"key":"1593_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"D Slamon","year":"1989","unstructured":"Slamon D, Godolphin W, Jones L, et al. Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707\u201312.","journal-title":"Science."},{"key":"1593_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"D Slamon","year":"1987","unstructured":"Slamon D, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science. 1987;235:177-82.","journal-title":"Science."},{"key":"1593_CR21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ijrobp.2009.12.011","volume":"77","author":"J Albert","year":"2010","unstructured":"Albert J, et al. Estrogen\/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys. 2010;77:1296\u2013302.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"1593_CR22","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","volume":"353","author":"M Piccart-Gebhart","year":"2005","unstructured":"Piccart-Gebhart M, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353:1659\u201372.","journal-title":"N Engl J Med."},{"key":"1593_CR23","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"E Romond","year":"2005","unstructured":"Romond E, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353:1673\u201384.","journal-title":"N Engl J Med."},{"key":"1593_CR24","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","volume":"10","author":"K Zee Van","year":"2003","unstructured":"Van Zee K, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10:1140\u201351.","journal-title":"Ann Surg Oncol."},{"key":"1593_CR25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1245\/ASO.2003.05.020","volume":"10","author":"R Hwang","year":"2003","unstructured":"Hwang R, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10:248\u201353.","journal-title":"Ann Surg Oncol."},{"key":"1593_CR26","doi-asserted-by":"crossref","unstructured":"Mittendorf E, et al. Size matters: incorporation of sentinel lymph node (SLN) metastasis size into a nomogram predicting non-SLN involvement in SLN-positive breast cancer patients. Cancer Res. 2010;70 (Suppl):117\u00a0s (Abstract PD106-108).","DOI":"10.1158\/0008-5472.SABCS10-PD06-08"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-1593-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-011-1593-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-1593-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T23:59:33Z","timestamp":1637279973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-011-1593-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1593"],"URL":"https:\/\/doi.org\/10.1245\/s10434-011-1593-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}